{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:18:30Z","timestamp":1776921510207,"version":"3.51.2"},"publisher-location":"Cham","reference-count":28,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030716967","type":"print"},{"value":"9783030716974","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-71697-4_17","type":"book-chapter","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T08:03:45Z","timestamp":1626681825000},"page":"205-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19"],"prefix":"10.1007","author":[{"given":"Amir","family":"Vahedian-Azimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Rahimibashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Kidde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Shahriary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Amin","family":"Pourhoseingholi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","unstructured":"Pan H, Peto R, Karim QA, Alejandria M, Swaminathan S (2020) Repurposed antiviral drugs for COVID-19 \u2013 interim WHO SOLIDARITY trial results. MedRxiv. https:\/\/doi.org\/10.1101\/2020.10.15.20209817","DOI":"10.1101\/2020.10.15.20209817"},{"issue":"8","key":"17_CR2","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/ATVBAHA.120.314558","volume":"40","author":"D Gustafson","year":"2020","unstructured":"Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K et al (2020) Overcoming barriers: the endothelium as a linchpin of coronavirus disease 2019 pathogenesis? Arterioscler Thromb Vasc Biol 40(8):1818\u20131829","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10234","key":"17_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and Endotheliitis in COVID-19. Lancet 395(10234):1417\u20131418","journal-title":"Lancet"},{"issue":"14","key":"17_CR4","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","volume":"116","author":"PC Evans","year":"2020","unstructured":"Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z et al (2020) Endothelial dysfunction in COVID-19: a position paper of the ESC Working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res 116(14):2177\u20132184","journal-title":"Cardiovasc Res"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"m810","DOI":"10.1136\/bmj.m810","volume":"368","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein R, Gr\u00e4ni C (2020) Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal. BMJ 368:m810. https:\/\/doi.org\/10.1136\/bmj.m810","journal-title":"BMJ"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"m1182","DOI":"10.1136\/bmj.m1182","volume":"368","author":"U Ravskov","year":"2020","unstructured":"Ravskov U (2020) Rapid response: cholesterol-lowering treatment may worsen the outcome of a COVID-19 infection. BMJ 368:m1182. https:\/\/doi.org\/10.1136\/bmj.m1182","journal-title":"BMJ"},{"issue":"3","key":"17_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","volume":"14","author":"X Wei","year":"2020","unstructured":"Wei X, Zeng W, Su J, Wan H, Yu X, Cao X (2020) Hypolipidemia is associated with the severity of Covid-19. J Clin Lipidol 14(3):297\u2013304","journal-title":"J Clin Lipidol"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/atm.2016.11.03","volume":"4","author":"DS Fedson","year":"2016","unstructured":"Fedson DS (2016) Treating the host response to emerging virus diseases: lesson learned from sepsis, pneumonia, influenza and Ebola. Ann Translat Med 4:421. https:\/\/doi.org\/10.21037\/atm.2016.11.03","journal-title":"Ann Translat Med"},{"issue":"3","key":"17_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","volume":"16","author":"Z Reiner","year":"2020","unstructured":"Reiner Z, Hatamipour M, Banach M, Pirro M, Sahebkar A (2020) Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci 16(3):490\u2013496","journal-title":"Arch Med Sci"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","volume":"134","author":"CS Kow","year":"2020","unstructured":"Kow CS, Hasan SS (2020) Meta-analysis of effect of statins on patients with COVID-19. Am J Cardiol 134:153\u2013155","journal-title":"Am J Cardiol"},{"issue":"10","key":"17_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Greco M, Zanella A (2020) Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 180(10):1345\u20131355","journal-title":"JAMA Intern Med"},{"key":"17_CR12","doi-asserted-by":"publisher","unstructured":"Yan H, Valdes AM, Vijay A, Wang S, Liang L (2020) Role of drugs affecting the renin-angiotensin-aldosterone system on susceptibility and severity of COVID-19: a large case-control study from Zheijang Province, China. MedRxiv. https:\/\/doi.org\/10.1101\/2020.04.24.20077875","DOI":"10.1101\/2020.04.24.20077875"},{"key":"17_CR13","doi-asserted-by":"publisher","unstructured":"Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Parikh SA (2020) Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-56210\/v1.1","DOI":"10.21203\/rs.3.rs-56210\/v1.1"},{"issue":"8","key":"17_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11739-020-02504-y","volume":"15","author":"R Rossi","year":"2020","unstructured":"Rossi R, Talarico M, Coppi F, Boriani G (2020) Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action. Intern Emerg Med 15(8):1573\u20131576","journal-title":"Intern Emerg Med"},{"issue":"1","key":"17_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13054-020-03154-4","volume":"24","author":"G Rodriguez-Nava","year":"2020","unstructured":"Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, Chung CW, Friedman HJ (2020) Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study. Crit Care 24(1):429. https:\/\/doi.org\/10.1186\/s13054-020-03154-4","journal-title":"Crit Care"},{"key":"17_CR16","doi-asserted-by":"publisher","unstructured":"Cariou B, Goronflot T, Timbert A, Boullu S, Wargny M (2020) Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study. Diabetes Metab 47(2):101202. https:\/\/doi.org\/10.1016\/j.diabet.2020.10.001","DOI":"10.1016\/j.diabet.2020.10.001"},{"issue":"24","key":"17_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018475","volume":"9","author":"O Saeed","year":"2020","unstructured":"Saeed O, Castagna F, Agalliu I, Xue X, Jorde UP (2020) Statin use and in-hospital mortality in diabetics with COVID-19. J Am Heart Assoc 9(24):e018475. https:\/\/doi.org\/10.1161\/JAHA.120.018475","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"17_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"XJ Zhang","year":"2020","unstructured":"Zhang XJ, Yibin W, Cai J, Guo J, Li H (2020) In hospital use of statin is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab 32(2):176\u2013187","journal-title":"Cell Metab"},{"key":"17_CR19","unstructured":"Social Security Health Insurance National Fund (2013) Use of statins: a consumption structure to be improved, major savings potential for the healthcare system. https:\/\/www.ameli.fr\/fileadmin\/user_upload\/documents\/29052013_DP_Usage_statines_mai_2013_vdef.pdf"},{"key":"17_CR20","doi-asserted-by":"publisher","unstructured":"Patoulias D, Katsimardou A, Stavropoulos K, Imrialos K, Doumas M (2020) Renin-anfiotensin system inhibitors and COVID-19: a systematic review and meta-analysis. Evidence for significant geographic disparities. Curr Hypertens Rep 22(11). https:\/\/doi.org\/10.1007\/s11906-020-01101-w","DOI":"10.1007\/s11906-020-01101-w"},{"issue":"19","key":"17_CR21","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","volume":"41","author":"GM Kuster","year":"2020","unstructured":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al (2020) SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 41(19):1801\u20131803","journal-title":"Eur Heart J"},{"issue":"25","key":"17_CR22","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"H Reynolds","year":"2020","unstructured":"Reynolds H, Adhikari S, Pulgarin C, Troxel A, Iturrate E, Johnson SB et al (2020) Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19. N Engl J Med 382(25):2441\u20132448","journal-title":"N Engl J Med"},{"issue":"8","key":"17_CR23","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","volume":"222","author":"KW Lam","year":"2020","unstructured":"Lam KW, Chow KW, Vo J, Hou W, Li H, Richman PS et al (2020) Continued in-hospital angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use in hypertensive COVID-19 patients is associated with positive clinical outcome. J Infect Dis 222(8):1256\u20131264","journal-title":"J Infect Dis"},{"issue":"22","key":"17_CR24","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","volume":"41","author":"C Gao","year":"2020","unstructured":"Gao C, Cai Y, Zhang K, Zhou L, Zhang Y (2020) Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 41(22):2058\u20132066","journal-title":"Eur Heart J"},{"issue":"12","key":"17_CR25","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J et al (2020) Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126(12):1671\u20131681","journal-title":"Circ Res"},{"issue":"1","key":"17_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J et al (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbe Infect 9(1):757\u2013760","journal-title":"Emerg Microbe Infect"},{"issue":"5","key":"17_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/HYPERTENSIONAHA.120.15989","volume":"76","author":"C-K Chan","year":"2020","unstructured":"Chan C-K, Huang Y-S, Liao H-W, Tsai IJ, Chu T-S (2020) Renin-angiotensin-aldosterone system inhibitors and risks of severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Hypertension 76(5):1563\u20131571","journal-title":"Hypertension"},{"key":"17_CR28","doi-asserted-by":"crossref","unstructured":"Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM et al (2021) Aspirin use is associated with decreased mechanical ventilation, ICU admission, and INhospital mortality in hospitalized patients with COVID-19. Anesth Anal 132(4):930\u2013941","DOI":"10.1213\/ANE.0000000000005292"}],"container-title":["Advances in Experimental Medicine and Biology","Identification of Biomarkers, New Treatments, and Vaccines for COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-71697-4_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T06:15:41Z","timestamp":1628057741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-71697-4_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030716967","9783030716974"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-71697-4_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"20 July 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}